Gepotidacin, an investigational antibiotic, proved noninferior to dual therapy for the treatment of uncomplicated urogenital gonorrhea, according to results of the phase III EAGLE-1 trial.

This has been the case throughout history, as gonorrhea has become resistant to medications like penicillin and other previous treatments. There have not been any documented cases in the U.S. of ...

From February 2022 to February 2023, they collected (using cotton swabs) and genetically sequenced bacterial samples from six ...

By recognizing the signs of gonorrhea—and better understanding your risk of infection—you can get tested and seek treatment, ...

A dangerous new strain of gonorrhea has medical professionals deeply concerned. This antibiotic-resistant “superbug” version of the sexually transmitted disease poses unprecedented risks ...

An era of untreatable gonorrhea may be approaching ... Advocacy for increased awareness on correct use of antibiotics among healthcare providers and the consumers, particularly in key populations ...

The medical community continues to monitor the development and spread of antibiotic-resistant gonorrhea strains. Research efforts focus on developing new treatment options and understanding the ...

Researchers identify key geographic and health factors that may predict the prevalence of antimicrobial-resistant gonorrhea in the United States.

According to the World Health Organization (WHO), hundreds of millions of new cases of bacterial sexually transmitted ...

They cautioned that the mixed results on gonorrhea, along with results from another recent study showing people taking doxy PEP had some evidence of resistance to a class of antibiotics for ...

Recce Pharmaceuticals’ synthetic gel successfully treated a range of skin infections in a phase 2 trial, leading the ...